ArticleArtificial intelligence in medicine2025
Pathway information on methylation analysis using deep neural network (PROMINENT): An interpretable deep learning method with pathway prior for phenotype prediction using gene-level DNA methylation.
Article in Artificial intelligence in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathway-level epigenetic modeling illuminates the methylation architecture to asthma risk across tissues.Epigenetics & chromatin · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDNA methylation is a key epigenetic marker that influences gene expression and phenotype regulation, and is affected by both genetic and environmental factors. Traditional linear regression methods such as elastic nets have been employed to assess the cumulative effects of multiple DNA methylation markers on phenotypes. However, these methods often fail to capture the complex nonlinear nature of the data. Recent deep learning approaches, such as MethylNet, have improved the prediction accuracy but lack interpretability and efficiency.
findingsTo address these limitations, we introduced Pathway Information on Methylation Analysis using a Deep Neural Network (PROMINENT), a novel interpretable deep learning method that integrates gene-level DNA methylation data with biological pathway information for phenotype prediction. PROMINENT enhances interpretability and prediction accuracy by incorporating gene- and pathway-level priors from databases such as Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). It employs SHapley Additive exPlanations (SHAP) to prioritize significant genes and pathways. Evaluated across various datasets, childhood asthma, idiopathic pulmonary fibrosis (IPF), and first-episode psychosis (FEP)-PROMINENT consistently outperformed existing methods in terms of prediction accuracy and computational efficiency. PROMINENT also identified crucial genes and pathways involved in disease mechanisms.
conclusionsPROMINENT represents a significant advancement in leveraging DNA methylation data for phenotype prediction, offering both high accuracy and interpretability within reasonable computational time. This method holds promise for elucidating the epigenetic underpinnings of complex diseases and enhancing the utility of DNA methylation data in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.